← Evidence map

ReviewCancer immunology, immunotherapy : CII2018

Targeting CTCFL/BORIS for the immunotherapy of cancer.

Dmitri LoukinovPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

20 papers cite it

2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 30390146